Clinical implications of reduced susceptibility to fluoroquinolones in paediatric Shigella sonnei and Shigella flexneri infections.

MLA

Thompson, Corinne N., et al. “Clinical Implications of Reduced Susceptibility to Fluoroquinolones in Paediatric Shigella Sonnei and Shigella Flexneri Infections.” The Journal of Antimicrobial Chemotherapy, vol. 71, no. 3, Mar. 2016, pp. 807–15. EBSCOhost, https://doi.org/10.1093/jac/dkv400.

APA

Thompson, C. N., Thieu, N. T. V., Vinh, P. V., Duc, A. N., Wolbers, M., Vinh, H., Campbell, J. I., Ngoc, D. T. T., Hoang, N. V. M., Thanh, T. H., The, H. C., Nguyen, T. N. T., Lan, N. P. H., Parry, C. M., Chau, N. V. V., Thwaites, G., Thanh, D. P., & Baker, S. (2016). Clinical implications of reduced susceptibility to fluoroquinolones in paediatric Shigella sonnei and Shigella flexneri infections. The Journal of Antimicrobial Chemotherapy, 71(3), 807–815. https://doi.org/10.1093/jac/dkv400

Chicago

Thompson, Corinne N, Nga Tran Vu Thieu, Phat Voong Vinh, Anh Nguyen Duc, Marcel Wolbers, Ha Vinh, James I Campbell, et al. 2016. “Clinical Implications of Reduced Susceptibility to Fluoroquinolones in Paediatric Shigella Sonnei and Shigella Flexneri Infections.” The Journal of Antimicrobial Chemotherapy 71 (3): 807–15. doi:10.1093/jac/dkv400.